EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
The validations confirm the completion of the applications and commence the scientific review process
The validations confirm the completion of the applications and commence the scientific review process
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
This agreement paves the way for the introduction of YESAFILI into the Canadian market
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Eugia Pharma Specialities restarts production at terminally sterilized product lines
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Subscribe To Our Newsletter & Stay Updated